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Varies with Cell Activation and Contains Novel
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Architecture*□S
Nadia Korfali‡, Gavin S. Wilkie‡, Selene K. Swanson§, Vlastimil Srsen‡,
Dzmitry G. Batrakou‡¶, Elizabeth A. L. Fairley‡, Poonam Malik‡, Nikolaj Zuleger‡,
Alexander Goncharevich‡, Jose de las Heras‡, David A. Kelly‡, Alastair R. W. Kerr‡,
Laurence Florens§, and Eric C. Schirmer‡**
A favored hypothesis to explain the pathology underlying
nuclear envelopathies is that mutations in nuclear enve-
lope proteins alter genome/chromatin organization and
thus gene expression. To identify nuclear envelope pro-
teins that play roles in genome organization, we analyzed
nuclear envelopes from resting and phytohemagglutinin-
activated leukocytes because leukocytes have a particu-
larly high density of peripheral chromatin that undergoes
significant reorganization upon such activation. Thus, nu-
clear envelopes were isolated from leukocytes in the two
states and analyzed by multidimensional protein identifi-
cation technology using an approach that used expected
contaminating membranes as subtractive fractions. A to-
tal of 3351 proteins were identified between both nuclear
envelope data sets among which were 87 putative nuclear
envelope transmembrane proteins (NETs) that were not
identified in a previous proteomics analysis of liver nu-
clear envelopes. Nuclear envelope localization was con-
firmed for 11 new NETs using tagged fusion proteins and
antibodies on spleen cryosections. 27% of the new pro-
teins identified were unique to one or the other of the two
leukocyte states. Differences in expression between ac-
tivated and resting leukocytes were confirmed for some
NETs by RT-PCR, and most of these proteins appear to
only be expressed in certain types of blood cells. Several
known proteins identified in both data sets have functions
in chromatin organization and gene regulation. To test
whether the novel NETs identified might include those
that also regulate chromatin, nine were run through two
screens for different chromatin effects. One screen found
two NETs that can recruit a specific gene locus to the
nuclear periphery, and the second found a different NET
that promotes chromatin condensation. The variation in
the protein milieu with pharmacological activation of the
same cell population and consequences for gene regula-
tion suggest that the nuclear envelope is a complex reg-
ulatory system with significant influences on genome
organization. Molecular & Cellular Proteomics 9:
2571–2585, 2010.
The nuclear envelope (NE)1 is a double membrane system
consisting of the intermediate filament nuclear lamin polymer
and associated proteins attached to the inner nuclear mem-
brane (INM) (1), nuclear pore complexes (NPCs) that direct
transport of soluble macromolecules in and out of the nucleus
(2), and the outer nuclear membrane (ONM) and associated
proteins. Structurally, the ONM is continuous with the endo-
plasmic reticulum (ER) and is studded with ribosomes (3), yet
it also contains unique proteins, many of which connect the
cytoskeleton to the NE (4). On the other side, lamins and many
INM proteins directly connect chromatin to the NE. Lamins
and an increasing number of nuclear envelope transmem-
brane proteins (NETs) have been linked to a similarly increas-
ing number of diseases ranging from muscular dystrophy to
neuropathy, dermopathy, lipodystrophy, bone disorders, and
progeroid aging syndromes (5, 6).
A favored hypothesis to explain how different NE proteins
can produce such a wide range of disease pathologies is that
chromatin-NE connections are disrupted with NE protein mu-
tations, yielding changes in gene regulation. This hypothesis
is supported by observations that the distribution of dense
peripheral chromatin is affected in fibroblasts from patients
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with NE-linked muscular dystrophy, cardiomyopathy, man-
dibuloacral dysplasia, and progeria (7–10). Furthermore, many
binding partners have been identified for NETs that are either
chromatin proteins, enzymes that modify chromatin proteins,
or regulators of gene expression (1, 11). These include mark-
ers of silent chromatin such as heterochromatin protein 1 (12)
and proteins that modify chromatin to a silent conformation
such as histone deacetylase 3 (13). The importance of the NE
to global genome organization has been underscored by sev-
eral recent studies that showed that affinity-based recruit-
ment of a specific chromosome locus by the NE both pulled
entire chromosomes to the periphery and affected gene reg-
ulation in complex ways (14–16).
To identify NE proteins likely to be involved in genome
organization, we turned to lymphocytes as a model system.
Lymphocytes in the resting state tend to have massive
amounts of dense peripheral chromatin as determined by
electron microscopy studies. Upon activation with phytohe-
magglutinin, this dense chromatin largely dissipates as the
cells actively express genes (17–20). Thus, to identify proteins
that might be involved in tethering heterochromatin to the NE
or in changing its organization, we analyzed the NE pro-
teomes of leukocyte populations (70% lymphocytes) in both
the resting and phytohemagglutinin (PHA)-activated states.
The previously validated subtractive approach was applied
(21) using microsomes and mitochondria, the principal mem-
brane contaminants expected, as subtractive fractions.
Many new NE proteins were identified that had not been
identified in previous NE proteomics investigations using liver
and neuroblastoma cells (21, 22). NE residence was con-
firmed for 12 novel NETs by expression of epitope-tagged
versions and using antibodies on tissue cryosections.
Roughly one-quarter of the proteins identified varied be-
tween the resting and activated states. Some NET differences
between the two data sets were confirmed by RT-PCR.
Among the known proteins identified were several that sug-
gest that changes in NE composition associated with PHA
activation contribute to gene regulation. Novel NETs identified
also appear to play significant roles in genome organization/
regulation as we found that several can either recruit a spe-
cific locus to the nuclear periphery or promote chromatin
condensation. As several studies have implicated misregula-
tion of chromatin organization in NE diseases (7, 8), these
newly identified NETs may contribute to the diverse patholo-
gies associated with NE diseases.
EXPERIMENTAL PROCEDURES
Preparation and Activation of Leukocytes—Human buffy coats
from healthy donors were obtained anonymously from the Scottish
National Blood Transfusion Service according to approved ethics
protocols. Buffy coats were diluted with phosphate-buffered saline
(PBS), and a peripheral blood mononuclear cell (PBMC) fraction was
isolated by centrifugation on Ficoll-Histopaque-1077 (Sigma) at
250  g for 30 min. Cells were diluted in PBS, pelleted, and resus-
pended in RPMI 1640 medium containing 10% fetal bovine serum
(FBS), 100 g/l penicillin, and 100 g/l streptomycin sulfate (In-
vitrogen). PBMCs were activated by addition of 2.5 g/ml PHA
(Sigma) for 7 days. To determine the composition of PBMC prepara-
tions, cells were analyzed by FACS using antibodies from Caltag
Medsystems to CD19 for resting B-cells and CD19/CD4 for activated
B-cells, CD3 for resting T-cells and CD3/CD45 for activated T-cells,
CD3/CD4 for resting helper T-cells and CD4/CD45 for activated
helper T-cells, CD3/CD8 for resting cytotoxic T-cells and CD8/CD45
for activated cytotoxic T-cells, and CD11b/CD14 for myeloid cells.
Preparation of Fractions—NEs were isolated using procedures
specifically modified for blood leukocytes and detailed previously
(23). In brief, nuclei were first isolated from PBMCs by hypotonic lysis
in 10 mM HEPES, pH 7.4, 1.5 mM MgCl2, 10 mM KCl, 2 mM DTT using
a “loose” Dounce homogenizer (Wheaton). Nuclei were pelleted at
1000  g for 10 min to separate them from small vesicles and
mitochondria that require higher speeds to pellet. To float/remove
contaminating membranes, nuclei were resuspended in SHKM (50
mM HEPES, pH 7.4, 25 mM KCl, 5 mM MgCl2, 1 mM DTT and 1.8 M
sucrose) and pelleted through a 5 ml 2.1 M sucrose cushion in an
SW28 swinging bucket rotor (Beckman) at 4 °C for 2 h at 82,000  g.
NEs were then prepared from isolated nuclei by two rounds of diges-
tion with DNase and RNase in 0.3 M sucrose, 10 mM HEPES, pH 7.4,
2 mM MgCl2, 0.5 mM CaCl2, 2 mM DTT for 20 min followed by layering
onto the same buffer with 0.9 M sucrose and centrifugation at 6000 
g for 10 min at 4 °C.
The PBMC cell populations had very little ER, so microsomes
representing contaminant membrane fractions were instead isolated
from rat liver using well established procedures (24, 25). In brief, liver
was diced and homogenized in SHKM using a motorized Dounce
homogenizer. After removing nuclei as for NE preparations, 0.5 mM
EDTA was added to inhibit metalloproteinases, and mitochondria and
other debris from postnuclear supernatants were also removed by
pelleting at 10,000  g for 15 min. The supernatant was made to 2 M
sucrose with SHKM and then overlaid with 1.86 and 0.25 M sucrose
layers. This was then subjected to centrifugation in an SW28 swinging
bucket rotor (Beckman) at 4 °C for 4 h at 57,000  g to float micro-
somes. The material between the 1.86 and 0.25 M layers was then
diluted 4-fold with 0.25 M SHKM and pelleted at 152,000 g in a type
45 Ti rotor (Beckman) for 1 h.
NE preparations were divided, and one portion was further ex-
tracted on ice with 400 mM NaCl, 25 mM HEPES, pH 8.0, 5 mM MgCl2,
10 mM DTT, 1% -D-octyl glucoside, and material used for mass
spectrometry analysis was pelleted at 15,000  g for 30 min and
washed in sterile H2O. Another portion of NEs and separate micro-
somes were further extracted with 0.1 N NaOH, 10 mM DTT, and the
material used for mass spectrometry was pelleted by centrifugation at
150,000  g for 30 min and washed three times in sterile H2O.
MudPIT—Two types of digestion were applied to NE and micro-
some pellets (supplemental Table S1). For the first, dried membrane
pellets were incubated overnight in 90% formic acid and 500 mg/ml
cyanogen bromide (CNBr). Ammonium hydroxide (NH4OH) was then
added to pH 8.5, solid urea was added to 8 M, and tris(2-carboxyl-
ethyl)phosphine hydrochloride (TCEP) was added to 5 M and incu-
bated for 30 min. Next free cysteines were alkylated with 20 mM
iodoacetamide (IAM) for 30 min prior to addition of endoproteinase
Lys-C (Roche Applied Science) at a 1:100 (w/w) enzyme to protein
ratio for 6 h at 37 °C. Urea was diluted to 2 M with 0.1 M Tris-HCl, pH
8.5, and CaCl2 (0.5 mM) and modified trypsin (1:100, w/w) were added
for 12 h at 37 °C. Digestions were quenched with 5% formic acid (25).
For the second digestion (Ti), pellets were solubilized in 0.1 M Tris-
HCl, pH 8.5, 8 M urea, 5 mM TCEP. IAM was added to 10 mM for 30
min, and endoproteinase Lys-C and trypsin digestion was performed
as above. Samples were centrifuged for 30 min at 17,500  g.
Supernatants were analyzed by MudPIT, whereas pellets were resus-
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pended in 0.1 M sodium carbonate (Na2CO3), pH 11.5, 8 M urea, 5 mM
TCEP for 30 min and then in 10 mM IAM for 30 min and then further
digested with proteinase K for 4 h at 37 °C and also analyzed by
MudPIT.
Each digested sample was analyzed independently by MudPIT as
described previously (26–28) using a flow rate of 200–300 nl/min.
12–15 cycles (supplemental Table S1) of 120 min each of increasing
salt concentrations followed by organic gradients (5–80% acetonitrile
with 0.1% formic acid) slowly released peptides directly into the mass
spectrometer (26). The last two or last five (of 12 or 15) chromatog-
raphy steps consisted of a high salt wash with 5% acetonitrile, 0.1%
formic acid, 500 mM ammonium acetate followed by the acetonitrile
gradient. The distal application of a 2.5-kV voltage electrosprayed the
eluting peptides directly into ion trap mass spectrometers equipped
with a nano-LC electrospray ionization source (ThermoFinnigan).
Each full MS scan (from 400 to 1600 m/z) was followed by three
(XP-Deca) or five (LTQ) MS/MS events (supplemental Table S1) using
data-dependent acquisition where the first most intense ion was
isolated and fragmented by collision-induced dissociation (at 35%
collision energy) followed by the second to third or fifth most intense
ions. The raw mass spectrometric data may be downloaded from
ProteomeCommons.org by going to the URL indicated in Table I and
then inserting the hash identifiers from Table I.
RAW files were extracted into ms2 file format (29) using RAW_
Xtract v.1.0 (30). For the human PBMC data set (supplemental
Table S2), MS/MS spectra were queried for peptide sequence infor-
mation using SEQUEST v.27 (revision 9) (31) against 30,552 human
proteins (non-redundant NCBI sequences on March 4, 2008) plus 162
sequences from usual contaminants (e.g. human keratins etc.) and
313 previously identified NETs (21). To estimate false discovery rates,
each non-redundant protein entry was randomized and added to the
database bringing the total search space to 61,864 sequences
(supplemental Table S1). For the mouse (supplemental Table S3) (21)
and rat (supplemental Table S4) liver microsomal membrane data
sets, the species-specific databases consisted of 29,998 mouse or
28,400 rat proteins (non-redundant NCBI sequences on June 22,
2007 and July 10, 2006, respectively) complemented as described
above with sequences for contaminants and previously identified
NETs as well as their corresponding randomized sequences
(supplemental Table S1). MS/MS spectra were searched without
specifying differential modifications, but 57 Da were added stati-
cally to cysteine residues to account for carboxamidomethylation. No
enzyme specificity was imposed during searches, setting a mass
tolerance of 3 amu for precursor ions and of 0.5 amu for fragment
ions.
Results from different runs were compared using DTASelect and
Contrast (32). Spectrum/peptide matches were retained if at least 7
amino acids long with ends complying with proteolytic specificity, e.g.
Met, Lys, or Arg before the amino terminus and at the carboxyl
terminus of peptides for those cleaved with CNBr prior to trypsin
digestion. Other criterion were Cn 0.08, XCorr 1.8 for singly, 2.0
for doubly, and 3.0 for triply charged spectra, and a maximum Sp rank
of 10. For proteinase K-digested samples, no specific peptide ends
were imposed, but the Cn cutoff was increased to 0.15 (33), and
XCorr minima were increased to 2.5 for doubly and 3.5 for triply
charged spectra (SEQUEST parameters for the spectrum to peptide
matches leading to the identification of proteins from human PBMC
NEs, mouse liver microsomes, and rat liver microsomes are provided
in supplemental Tables S2A, S3A, and S4A, respectively). Peptide hits
from all analyses were merged to establish a master list of proteins
identified by at least two peptides or one peptide with two indepen-
dent spectra (see supplemental Tables S2B, S3B, and S4B for the
detailed peptide and spectral counts of proteins detected by MudPIT
analysis of human PBMC NEs, mouse liver microsomes, and rat liver
microsomes, respectively). Based on the merged detected peptides,
proteins could fall into three categories following the parsimony prin-
ciple. (i) Proteins detected by the exact same set of peptides were
grouped together because they could not be distinguished based
on the available peptide data (see column named “Proteins in
Group” in supplemental Tables S2–S4), and only one arbitrarily
selected representative protein entry is reported for such groups
of proteins (see column labeled “Locus” in supplemental
Tables S2–S4). (ii) Proteins with at least one peptide uniquely
mapping to them were considered unique entries. (iii) Subset pro-
teins for which no unique peptides were detected were removed
from the final list of identified proteins.
Identifications mapping to shuffled peptides were used to estimate
false discovery rates. Spectral FDR was calculated as follows.
Spectral FDR
2 SHUFFLED_SpectralCounts
Total_SpectralCounts
 100
(Eq. 1)
Protein level FDR was calculated as follows.
Protein FDR
SHUFFLED_Proteins
Total_Proteins
 100 (Eq. 2)
Under these criteria, the final FDRs at the protein and peptide levels
were on average 1.5 and 0.5%, respectively (supplemental
Tables S2B–S4B, bottom).
To estimate relative protein levels, normalized spectral counts were
calculated for each non-redundant protein as described (34–36).
(NSAF)i
(SpectralCount/Length)i

k1
N
(SpectralCount/Length)k
(Eq. 3)
We implemented a new algorithm on this data set to refine spectral
counts to deal with peptides shared between multiple proteins (37).
For each run, dNSAFs were calculated based on distributed spectral
counts in which shared spectral counts were distributed based on
spectral counts unique to each isoform (supplemental Tables
S2B–S4B).
Bioinformatics Analysis—To be able to directly compare the lists of
proteins detected in the human PBMC NEs and rodent liver micro-
some data sets, proteins were mapped to an Ensembl gene to re-
move redundancy from differences in protein annotations. Human
gene orthologous groups were identified with Ensembl release 48 (38)
to remove redundancy and false variation that might have resulted
from differences in human and rodent gene assignments. Ortholo-
gous group IDs were sorted according to frequency of detection in
the NE and microsome runs, relative levels (determined by averaged
dNSAF values), membrane helix prediction (determined using
TMHMM 2.0; http://www.cbs.dtu.dk/services/TMHMM-2.0/ (39)), and
dNSAF ratios between values measured in NEs versus microsomes
(supplemental Table S5).
Biologically interesting GO terms and their corresponding child
terms were retrieved from the mySQL database AmiGO (http://
amigo.geneontology.org (40)). To ensure a fair comparison for term
enrichment, only human mapped genes in our data set were consid-
ered. These were compared with the genomics data set of human
Ensembl genes as well as those GO defined as having nuclear local-
ization. For a given GO term, the fraction of genes containing that
term or any of the child terms was calculated for all data sets. The
-fold difference was calculated by dividing this fractional value from
our data set of interest by the value from the reference group.
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Comparison of expression levels in different blood cell lineages
was done by downloading numbers for each NET and blood cell type
from BioGPS (http://biogps.gnf.org/#gotowelcome (41)) and calcu-
lating the -fold expression over the median value from all cell types
tested in this transcriptome database. Thus, the numbers not only
reflect differences among the blood cell lineages but also differences
with other tissues.
Antibodies and Western Blotting—Antibodies used were GAPDH
(Enogene, E1C604), Calreticulin (Cell Signaling Technology, 2891S),
Calnexin (Stressgen, SPA-860), lamins A and B1 (3262 and 3931;
Ref. 42), Nup153 (Covance), and Nup358 (raised against recombi-
nant human protein amino acids 2595–2881; a kind gift from F.
Melchior). NET antibodies were rabbit polyclonal antibodies gener-
ated to peptides from human sequences by Millipore, Tmem126
(06-1037), C17orf62 (06-1033), C17orf32 (06-1035), and MARCH5
(06-1036), and the previously characterized NETs NET31/
Tmem209 (06-1020), SUN2 (06-1038). All fluorophore-conjugated
secondary antibodies were minimally cross-reactivity from donkey
(Jackson ImmunoResearch Laboratories) or goat (Molecular Probes).
To increase lamina solubility, PBMC or liver NEs were incubated on
ice in 50 mM Tris-HCl, pH 7.4, 150 mM NaCl, 2 mM MgCl2, 0.2%
Nonidet P-40 in the presence of protease inhibitor mixture (Roche
Applied Science, 11 873 580 001) for 15 min and then sonicated in a
4 °C sonic bath. Microsomes were treated similarly. Protein concen-
trations of liver NEs and microsomes (see Fig. 5) were determined by
Bradford assay before adding sample buffer (100 mM Tris, pH 6.8, 4
M urea, 2% SDS, 50 mM DTT, 15% sucrose), heating at 65 °C, and
then sonicating again in a 4 °C sonic bath. PBMC NEs and micro-
somes were adjusted for equal loading based on Coomassie Blue
staining on polyacrylamide gels (see Fig. 3A). Proteins were resolved
by SDS-PAGE and transferred to nitrocellulose membrane (LI-COR
Biosciences). Membranes were blocked in PBS, 5% milk, 0.2%
Tween. Primary antibodies were diluted in this buffer (1:200 for Milli-
pore NET peptide antibodies, 1:500 for calreticulin, 1:200 for calnexin,
and 1:2000 for lamin A) and allowed to incubate overnight at 4 °C.
Secondary IR800-conjugated goat anti-rabbit antibodies (LI-COR
Biosciences) were added at 1:5000 dilution at RT for 2 h. Visualization
and quantification were performed using a LI-COR Odyssey system
and software (Odyssey 3.0.16) using median background subtraction.
Three independent blots were run for each NET and control, and
averages from all three are presented in Fig. 5B.
Plasmid Construction—IMAGE clones for human NETs were ob-
tained from RZPD and Geneservice. NET gene names are followed by
IMAGE numbers or gene IDs in parentheses: STT3A (3891543),
TAPBPL (3916213), METTL7A (2900478), C17orf62 (2822930), IAG2
(3834858), Tmem109 (3453616), C20orf3 (3530962), C17orf32
(5429060), Sec11C (3895819), Tmem126A (1667589), AADACL1
(4815834), and Tmem41A (3838280). Coding sequences were ampli-
fied by PCR with added 5 and 3 restriction sites, sequenced from
both ends in intermediate cloning vectors, and then inserted into the
mammalian expression vector pmRFP with a carboxyl-terminal tag
(derived from Clontech pEGFP-N2 by replacing the GFP coding se-
quence with that of monomeric red fluorescent protein). Lamin A-GFP
was obtained from Anne Straube (Marie Curie Research Institute,
Oxted, UK), and calreticulin-GFP was obtained from Tom Rapoport
(Harvard, Boston, MA).
Cell Culture and Transient Transfection—HT1080, HT1080 5.1 (car-
rying a lac operator (lacO) array and lac repressor-GFP), HeLa cells
stably transfected with H2B-GFP, COS-7, and C2C12 cells were
maintained in high glucose DMEM with 4.5 g/liter glucose (Invitrogen)
supplemented with 10% fetal bovine serum (FBS), 100 g/l penicil-
lin, and 100 g/l streptomycin sulfate (Invitrogen). PBMCs were
maintained in RPMI 1640 medium with 10% FBS and antibiotics.
PBMCs were activated with 2.5 g/ml PHA (Sigma) for 7 days.
Adherent cells destined for microscopy were plated on coverslips,
and DNA was transfected the next day using FuGENE 6 (Roche
Applied Science) according to the manufacturer’s instructions.
Immunofluorescence Microscopy—After 30 h, cells were either
directly fixed for 7 min in 3.7% formaldehyde or washed with PBS;
then extracted for 1 min with 1% Triton X-100, 25 mM Tris, pH 8.0, 150
mM KOAc, 15 mM NaCl, 5 mM MgCl2; washed again with PBS; and
then fixed with formaldehyde. For antibody staining, cells that were
not pre-extracted were permeabilized for 6 min in 0.2% Triton X-100
after fixation. Cells were then blocked with 10% FBS, 200 mM glycine
in PBS and incubated for 40 min at RT with relevant antibodies. DNA
was visualized with Hoechst 33342 or 4,6-diamidino-2-phenylindole
dihydrochloride (DAPI) and coverslips mounted in Fluoromount-G
(EM Sciences). For structured illumination (OMX) microscopy, Alexa
Fluor secondary antibodies (Molecular Probes) were used. Most im-
ages were obtained using a Nikon TE-2000 microscope equipped
with a 1.45 numerical aperture 100 objective, Sedat quad filter set,
and CoolSnapHQ High Speed Monochrome charge-coupled device
camera (Photometrics). Structured illumination images (Fig. 4C) were
taken on the OMX system at the University of Dundee microscopy
facility (details described at http://microscopy.lifesci.dundee.ac.uk/
omx/).
For cryosections, fresh rat spleen cut into 2–3-mm cubes were
embedded in optimal cutting temperature compound (Tissue-Tek),
snap frozen in liquid nitrogen, and maintained at 80 °C. Sections
were cut on a Leica CM 1900 cryostat at 6–8-m thickness and fixed
in 20 °C methanol. After rehydration, sections were incubated with
NET antibodies overnight at 4 °C followed by secondary antibodies as
above. Cryosection images were recorded using an SP5 confocal
system (Leica) with 63 oil 1.4 numerical aperture objective using
argon and UV lasers. Micrographs were saved from source programs
as .tif files and prepared for figures using Photoshop 8.0.
The positional distribution of the lacO array was determined using
a macro (available on request) written in Visual Basic within Image Pro
Plus. In brief, the total nuclear area was automatically measured on
DAPI images, and the area was then divided into five equal regions of
interest through eroding 20% of the total area from the outer limits of
the DAPI-defined nucleus. The nuclear sector containing the lacO
spot was determined and exported to Microsoft Excel where the
results from each cell were summed.
Images of chromatin condensation in Fig. 8 were generated from
60-h post-transfection cells fixed with formaldehyde using a wide
field DeltaVision microscope (Applied Precision) using a 60 Plan
Apo oil objective. Image stacks (0.2-m steps) were deconvolved
using DeconQ and processed using SoftWorks.
Electron Microscopy—For transmission electron microscopy, whole
PBMCs or isolated NEs were fixed in 3% glutaraldehyde in 0.1 M
sodium cacodylate, pH 7.3 for 2 h; washed in 0.1 M sodium cacodylate;
postfixed in 1% osmium tetroxide for 45 min; washed again; and de-
hydrated in 50, 70, 90, and 100% normal grade acetones for 10 min
each and then for a further two 10-min changes in analar acetone.
Samples were then embedded in Araldite resin. 60-nm-thick sections
were cut on a Reichert OMU4 ultramicrotome (Leica), stained in uranyl
acetate and lead citrate, and then viewed in a Phillips CM120 transmis-
sion electron microscope. Images were taken at 100 kV at 11,000
magnification using a Gatan Orius charge-coupled device camera.
RESULTS
Generation of Lymphocyte-enriched Populations and NE
Fractions—NEs were prepared from PBMCs using methods
specially optimized for blood cells (23) (Fig. 1A). Central to
these methods is isolating clean nuclei from the rest of the cell
(Fig. 1B) that are subsequently digested with DNase and
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RNase and salt-washed to remove most of the nuclear con-
tents (Fig. 1C). Even after such isolation, NEs maintain strong
connections to partners such as peripheral chromatin (Fig.
1D). Prior to mass spectrometry, NEs were further extracted
with 1% -octyl glucoside, 400 mM NaCl or 0.1 N NaOH that
enriched for proteins associated with the insoluble intermedi-
ate filament lamin polymer or integral membrane proteins,
respectively. Some well characterized NETs distribute to one
or the other fraction (21, 22); hence, both detergent/salt- and
NaOH-extracted fractions were analyzed to be comprehen-
sive. Both extractions remove most contaminants so that only
strongly bound and relevant partners should remain.
PBMCs were 70% lymphocytes as determined by FACS
and antibody staining for CD antigens (Fig. 2A). PBMC NEs
were isolated with or without PHA stimulation, which mimics
immune responses (43) and increased activated cells 	3-fold
(Fig. 2, B and C). PHA activation also results in dissolution of
dense chromatin at the nuclear periphery (17–20). Staining of
cells with the DNA-binding dye acridine orange confirmed the
reduction of denser chromatin at the periphery. Acridine or-
ange has been reported to bind more strongly to single-
stranded DNA and thus gives a brighter signal in actively
transcribed chromatin regions with condensed chromatin not
allowing efficient intercalation (44). Thus, a weaker signal
concentrated largely at the periphery was observed in un-
stimulated lymphocytes, whereas a brighter signal that was
more diffuse through the nucleoplasm was observed for PHA-
activated cells (Fig. 2D). This was further confirmed at the
ultrastructural level as electron microscope images of the
cells revealed significant differences in the chromatin distri-
bution. Although patches could still be observed at the pe-
riphery in PHA-activated cells, they were less dense and
broken (Fig. 2E). Proteins identified in the PBMC data sets
would thus likely include proteins involved in chromatin re-
modeling, and some of these proteins might be highlighted by
differences between proteins identified in the unstimulated
and PHA-activated PBMC NE fractions.
Microsomes were prepared separately as a comparative/
subtractive fraction as they are rich in the main expected
transmembrane protein contaminants from the ER, which is
continuous with the NE. Thus, they provide a mechanism to
distinguish INM proteins and ONM-enriched proteins from
those such as ribosomes that inhabit both the ONM and ER.
Because isolated lymphocytes have very little ER, we used
rodent liver for production of microsomes. Actual contamina-
tion of NE fractions with ER was minimal because, although
some single membrane vesicles can be observed by electron
microscopy (see Fig. 1D), ER markers such as calreticulin and
calnexin were undetectable in the crude PBMC NE fractions
(Fig. 3). Conversely, NE proteins such as lamin A and the NET
LAP2 were not detectable in microsome fractions (Fig. 3),
indicating that the hypotonic lysis step only disrupted the
plasma membrane and did not contribute NE membranes to
the microsome fraction.
To remove donor variation as a factor in potential differ-
ences measured between unstimulated and PHA-activated
PBMCs, each PBMC preparation was divided in two: half was
FIG. 1. Cellular fractionation of PBMCs. A, method schematic.
Crude nuclei prepared from hypotonic lysis of PBMCs were cleaned
of contaminating cellular structures by gradient centrifugation to float
contaminating membranes while pelleting the denser nuclei. Crude
NEs were prepared by digesting/extracting nuclear contents from
isolated nuclei. Before MudPIT analysis, these were further extracted
with 1% -octyl glucoside, 400 mM NaCl or 0.1 N NaOH to enrich for
proteins associated with the insoluble lamin polymer or integral mem-
brane proteins, respectively. B, buffy coats from human blood were
separated on Ficoll-Hypaque density gradients to enrich for mono-
nuclear leukocytes (left panel). The cells were swollen hypotonically
(middle panel) and Dounce homogenized to release nuclei (right
panel), which were then further purified on sucrose gradients. Phase-
contrast light microscope images are shown. Scale bar, 10 m. C,
enrichment for NEs by chromatin digestion. DAPI staining for DNA
visualizes significant nuclear chromatin content in an isolated PBMC
nucleus (left panel) and the loss of most of this material after two
rounds of digestion with DNase and RNase, each followed by salt
washes (two right panels). A fluorescence microscope image is
shown. Scale bar, 5 m. D, ultrastructure of isolated NEs. Electron
micrographs of PBMC NEs show that most membranes in the pop-
ulation are the characteristic double membrane with little contamina-
tion from single membrane vesicles. Arrows point to positions of
NPCs. In some places, the hypotonic treatment used to swell the NEs
while digesting/extracting most of the chromatin resulted in mem-
brane blebbing. These NEs were further extracted with salt and
detergent to enrich for proteins associated with the intermediate
filament lamin polymer or with an alkaline treatment to enrich for
transmembrane proteins prior to analysis by MudPIT. After such
treatment, no structure remains that can be readily discerned by EM
with the characteristics of NEs. Scale bar, 0.2 m.
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treated with PHA, and the other half was used as unstimu-
lated. Some degree of variation between blood donors was
expected because of the wide variation in human immune
responses, so donor variation was averaged out within each
condition by combining NEs isolated from at least 15 separate
preparations for analysis. Combining this large number of
samples was necessary for the independent reason that the
vast majority of material was lost in isolating clean NEs from
PBMCs. In this study, it was not possible to further control for
variation due to factors such as age or racial differences as all
blood donor information was anonymous, but all buffy coats
were obtained within 2 days of donation. The combined NE
preparations were divided and extracted with either 0.1 M
NaOH or 1% -octyl glucoside, 400 mM NaCl, and insoluble
material was pelleted. The alkali extraction should have en-
riched for transmembrane proteins, and so vesicles were
pelleted at 150,000 g for 30 min, whereas the detergent/salt
extraction should have removed membranes and enriched for
both soluble and transmembrane proteins strongly associated
with the higher order intermediate filament lamin polymer;
these proteins were pelleted at 15,000  g for 30 min.
MudPIT Analysis—After extraction, pellets of isolated NE
fractions were digested with either a combined cyanogen
bromide-endoproteinase Lys-C-trypsin treatment or with a
combined endoproteinase Lys-C-trypsin treatment. For the
latter, treatment material that could be pelleted at 17,500  g
for 30 min was subsequently digested with proteinase K. The
multiple and processive digestions were favored over direct
FIG. 2. PBMC composition. A, cells treated as for NE purification
were incubated with CD markers for different blood cell types and
analyzed by flow cytometry. The percentage of each cell type for
PBMC composition in leukocytes is graphed. B, percentage of leu-
kocytes in the total population. C, percentage of lymphocyte activa-
tion in the different PBMC populations measured by appearance of
surface markers. Error bars in A, B, and C indicate standard deviation.
D, PHA activation gauged by changes in nucleotide distribution using
acridine orange dye. Acridine orange intercalates more strongly with
single-stranded DNA than double-stranded DNA, so intensity to some
degree measures “open” DNA that is being actively transcribed. A
dashed white line delineates the periphery of the nucleus. The unstimu-
lated PBMCs have weak staining at the periphery of the nucleus and no
staining in some central areas. PHA-activated lymphocytes have more
uniform distributions and brighter staining, indicating more open DNA.
E, PHA activation effects on chromatin organization assessed by elec-
tron microscopy. The unstimulated cell is smaller and has more com-
pacted chromatin concentrated at the nuclear periphery. In the PHA-
activated cell, much of this dense peripheral chromatin has become less
compact, and both the cell and nucleus have increased in volume as the
activated cells are now rapidly transcribing DNA and making protein.
Images were taken at 11,000. Scale bar, 1 m.
FIG. 3. Fraction purity. A, Coomassie-stained gel of NE and mi-
crosome fractions analyzed. B, Western blot of the above fractions
stained with organelle markers. ER markers calreticulin and calnexin
were absent from NEs, whereas NE markers lamin B2 and the NET
LAP2 were absent from microsomes. Similar amounts of total pro-
tein were loaded. MM, microsomal membranes.
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replicates on the limiting material to better access material
tightly associated with the intermediate filament lamin poly-
mer that is resistant to 2% Triton X-100, 2 M NaCl, and even
4 M urea. Indeed, additional identifications were made from
the proteinase K-digested material (supplemental Table S2B).
Five separate MudPIT (27, 28) runs were performed for each
of the unstimulated and PHA-activated PBMC NE fractions,
three for the NaOH-extracted and two for the salt/detergent-
extracted NEs. Thus, using different extraction conditions and
different digestions and performing multiple runs were ex-
pected to provide comprehensive coverage to identify all
proteins in the PBMC NE. After removing redundancy by
converting protein IDs to orthologous gene groups, 3351 pro-
teins were identified between the unstimulated and PHA-
activated PBMC NE data sets, 2923 from the unstimulated
and 2839 from the PHA-activated cells, 2411 of which were in
both (supplemental Table S2B).
To complement previously published microsome data sets
isolated from mouse liver (21), microsome data sets were
separately generated from rat liver as a subtractive fraction
(supplemental Table S4). These newly acquired microsome
factions were treated similarly to the NE fractions, i.e. di-
gested with trypsin and proteinase K and analyzed on LTQ ion
trap mass spectrometers (supplemental Table S1). Another
potential contaminant is mitochondria, but as the mitochon-
drial proteome has been extensively studied, lists of mito-
chondrial proteins were generated from a previous mass
spectrometry study of that organelle (45) for subtraction in-
stead of reanalyzing mitochondria (supplemental Table S5).
After subtracting 177 proteins that were previously identified
in mitochondria, 2756 proteins remained in unstimulated
PBMC NEs, 2760 remained in PHA-activated PBMC NEs, and
3174 remained in total. Using microsomes strictly as an ab-
solute subtractive fraction would have resulted in loss of
several well characterized NETs that have been demonstrated
to inhabit both the NE and ER. For example, emerin, one of
the most established INM NETs (46), was detected in both NE
and microsome data sets (supplemental Table S5) in agree-
ment with the fact that emerin also functions in the ONM, ER,
and interstitial discs (47–49). Moreover, as a recent elegant
proteomics study suggests that at least a third of all proteins
have multiple cellular localizations (50), we reasoned that
absolute subtraction would also remove relevant identifica-
tions. Thus, proteins were ordered according to an estimate of
abundance based on normalized spectral counts (dNSAF)
(35), and NE data sets were restricted to those proteins either
not detected in the microsomes or at least 5more abundant
than in the microsome fractions based on their NSAF values,
leaving 2183 proteins in unstimulated PBMC NEs, 2141 in
PHA-activated, and 2542 in total (supplemental Table S5).
This large number of proteins associated with the NE in-
cludes chromatin proteins and other factors that are tethered
directly or indirectly to both INM and ONM proteins and so,
although they can associate with the NE, are not necessarily
primarily resident at the NE. The subset of NETs is more likely
to be enriched at the NE and constitutes the surest NE core
components in PBMCs. These proteins include all 13 of the
previously well characterized NETs, 39 NETs previously de-
tected in the liver NE data sets (21), and 423 proteins pre-
dicted to contain at least one transmembrane domain by
TMHMM or membrane anchor by SignalP. Based on available
GO terms and annotations, we selected 87 of these proteins
as putative blood NETs (supplemental Table S5). It is of note
that five of 12 proteins we further characterized for NE target-
ing (see below) did not pass the criterion of 5-fold enrichment
over microsomes once the new rat liver microsome data set
was acquired. However, NE residence was confirmed for all
five, indicating that our selection criteria were very stringent
and that additional NETs are likely to be found in this data set.
Confirmation of NE Residence—The putative NETs identi-
fied could be in the INM and/or in the ONM that is continuous
with the ER or be contaminants. To directly test the validity of
novel protein identifications, 12 putative NETs from PBMC
data sets were cloned as tagged fusions and expressed in
cells to determine whether they target to the NE. Adherent
tissue culture cells were used instead of freshly isolated PB-
MCs because lymphocytes are very difficult to transfect, and
their small cytoplasm made it difficult to distinguish the NE
from the ER. To be able to clearly distinguish the NE from the
ER and other cell membranes, adherent flat HT1080 cells
were used for this analysis because lymphocytes are round
suspension cells with little ER that is packed closely around
the nucleus. Another issue is that, when overexpressed, NETs
tend to saturate binding sites at the NE and accumulate in the
ER, making clear confirmation of NE targeting difficult (Fig.
4A, left panels). To get around this problem, most of this
extraneous material was removed with a prefixation detergent
extraction. Most previously characterized NETs resist a pre-
fixation extraction with 1% Triton X-100 and 400 mM KCl
presumably because of tight associations with the intermedi-
ate filament lamin polymer (e.g. emerin; Fig. 4A, top panels),
whereas most ER proteins (e.g. calreticulin; Fig. 4A, middle
panels) are extracted with this treatment. Staining for lamins is
also shown as co-localization (yellow) with this well defined
NE protein, indicating NE localization. One of the novel NETs
identified here, C20orf3, behaved similarly to the well charac-
terized NET emerin in this assay (Fig. 4A, bottom panels). In
all, ten of the 12 putative NETs tested were retained at the NE
after a prefixation detergent extraction (Fig. 4; all except
Tmem126A and METTL7A). The putative NETs Tmem41A and
Tmem126A both failed to be expressed in the HT1080 cells
first tested, but Tmem41A was expressed and targeted to the
NE in COS-7 cells and resisted the detergent pre-extraction
(Fig. 4B, bottom left). Tmem126A also failed to be expressed
in COS-7 cells but was expressed and targeted in lympho-
cytes, which due to their small size and being suspension
cells could not be properly tested for resistance to detergent
pre-extraction (Fig. 4B, bottom right). METTL7A exhibited a
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concentration at the nuclear periphery that co-localized with
lamins but was never observed after a pre-fixation detergent
extraction (data not shown).
As the NE is comprised equally of INM and ONM, some
NETs may preferentially accumulate in one or the other sub-
compartment. A recent study used three-dimensional struc-
tured illumination microscopy (OMX) to distinguish INM from
ONM localization of lamins in cells when co-stained for pro-
teins from the nuclear pore nucleoplasmic (Nup153) or cyto-
plasmic (Nup358) face (51). We have previously used this
system to test several NETs identified in the earlier liver pro-
teomics data sets (52). Control NET LAP2 and all the new
NETs tested here accumulated in the INM as both the NET
(red) and Nup153 (green) localize to the same ring, whereas an
inner NET ring was observed compared with Nup358 (Fig.
4C). In contrast to the NETs, a separable inner Nup153 ring
was observed against the ER protein calreticulin. Yellow co-
localization was not generally observed in this system be-
cause the resolution of OMX microscopy is sufficient to dis-
tinguish the NPC proteins that are at 120-nm gaps in the
membrane from NETs that are inserted in the membrane itself.
Even METTL7A, the putative NET that was not resistant to the
detergent pre-extraction, appeared in the INM.
To test localization of endogenous proteins, polyclonal an-
tibodies were generated to three novel NETs (C17orf32,
Tmem126A, and C17orf62). Each recognized a protein of the
correct size in immunoblots (Fig. 5A). First, to test whether
NETs were principally in the NE or inhabited multiple cellular
localizations as has been indicated for roughly 40% of the
human proteome (50), antibodies were used on Western blots
comparing NE and microsome fractions. Tmem126A and
C17orf62 were exclusively in the NE fraction, but about a third
of C17orf32 occurred in the microsome fraction (Fig. 5B). This
is similar to the previously characterized NET31/Tmem209
that was detected in both the PBMC NE data sets and the
earlier liver NE data set (52).
The Tmem126A and C17orf62 antibodies yielded strong
and distinctive staining at the nuclear periphery when used on
cryosections from rat spleen (Fig. 5C). The nuclei are clearly
visualized with the DAPI DNA stain, and the antibody staining
is concentrated in a crisp rim just surrounding the nucleus that
is very similar to that observed with antibodies to the well
characterized NET SUN2. C17orf62 and C17orf32 both re-
sisted pre-extraction with Triton X-100 when expressed as
fusions in cell lines, and similarly, the antibodies to these
NETs yielded a rim stain in cultured cells pre-extracted with
detergent. Adherent tissue culture cells were used again be-
cause lymphocytes have little cytoplasm and do not with-
FIG. 4. mRFP fusions confirm NE targeting for several novel
PBMC NETs. A, HT1080 cells expressing NETs fused to mRFP were
directly fixed (left) or extracted with Triton X-100 prior to fixation
(right). The NE is marked by lamin A in green so that yellow indicates
co-localization of the NET at the NE. The directly fixed emerin image
has part of an untransfected cell, confirming that none of the NET
staining at the nuclear rim is due to bleed-through from the lamin A
channel. Note that prefixation extraction affects morphology and
sometimes leaves aggregated protein in the cytoplasm. The emerin
control and new NET C20orf3 are retained after extraction, whereas
the ER protein calreticulin is not. Scale bar, 10 m. B, other NET-
mRFP fusions were similarly pre-extracted and retained at the NE.
Tmem41A is shown in COS-7 cells because it was not expressed in
HT1080 cells, and Tmem126A is shown in Jurkat cells because it
failed to be expressed in either HT1080 or COS-7 cells. Scale bar, 10
m. C, inner versus outer nuclear membrane targeting. If a NET (red)
is in the INM it should appear in the same plane as the nuclear basket
protein Nup153 (green, left) and internal to the cytoplasmic filament
protein Nup358 (green, right) using structured illumination micros-
copy. Characterized NET LAP2 and most new NETs tested ap-
peared in the INM. One INM NET, METTL7A, did not resist Triton
pre-extraction. Scale bars, 5 m.
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stand the prefixation extraction well. However, C2C12 cells
were used instead of the HT1080 cells used earlier for target-
ing of fusion proteins. According to available transcriptome
data, all the NETs for which we had antibodies were at least
weakly expressed in C2C12 cells, whereas some were not
expressed at all in HT1080 cells. This allowed confirmation
that Tmem126A also resists detergent pre-extraction (Fig.
5D). Several proteins identified in these data sets were previ-
ously characterized proteins that had other reported cellular
localizations. Among these was MARCH5, previously re-
ported to be a mitochondrial protein that possibly contributes
to perinuclear localization of mitochondria (53). Although
widely staining throughout the cytoplasm in non-extracted
cells (data not shown), antibodies to MARCH5 (Fig. 5A) also
yielded nuclear rim staining after the detergent pre-extraction
(Fig. 5D, right panels), indicating that the endogenous protein
has a separate function at the NE. Thus MARCH5 is among
the estimated 40% of cellular proteins that have multiple
cellular localizations (50).
Changes in PBMC NE Composition following PHA Activa-
tion—Of the 87 core putative new PBMC NETs (sup-
plemental Table S5), 14% uniquely appeared in the unstimu-
lated PBMC NE fraction, and 14% uniquely appeared in the
PHA-activated PBMC NE fractions with 72% shared between
both conditions. These numbers were similar when consider-
ing all transmembrane proteins identified (73% shared) or
both transmembrane and soluble proteins identified (72%
shared). Differences between the unstimulated and PHA-stim-
ulated fractions were also observed in RNA expression levels
for NETs that appeared in both fractions that correlated with
peptide recovery. For example, four peptides were recovered
for AADACL1 in the PHA-activated versus seven in the un-
stimulated lymphocytes (Fig. 6A and supplemental Table
S2B), and correspondingly, AADACL1 transcript levels were
reduced in PHA-activated lymphocytes to 60% of the level in
unstimulated lymphocytes (Fig. 6B). The trends for expression
changes also agreed with estimated protein levels for
C17orf62, TAPBPL, and FAM3C.
Many of the novel NETs identified that were directly tested
here varied not only between the unstimulated and PHA-
activated leukocytes but appeared to be uniquely expressed
in different blood cell lineages. Extracting relative transcript
levels from a large scale transcriptome data set that com-
pared RNA transcript levels across multiple tissues (41), most
of the novel NETs had completely distinct patterns of expres-
sion among 10 different blood cell types ranging from eryth-
roid cells to B-cells (Fig. 6C). Only IAG2 and Sec11C of those
shown had similar general patterns of expression, and only
Tmem41A and C17orf32 (not shown) were expressed similarly
in all lineages. The data are expressed relative to a median
value that was generated from a much wider range of tissues,
and these NETs ranged from10 the median value to nearly
60 (Fig. 6C). Thus, many of the novel NETs identified from
the PBMC proteomics are reasonably restricted in the tissues
and cell types in which they are expressed. The interpretation
of these results is tempered by the observation that some
changes in the population composition occur upon PHA ac-
tivation (Fig. 2A). Myeloid cells were found to increase, and
this is consistent with some of the NETs being more specific
to myeloid dendritic cells (Fig. 6C); however, the percentage
of myeloid cell-associated proteins at the NE did not increase.
This could be attributed to having already made a full identi-
fication of myeloid cell-associated proteins in the unstimu-
lated cells. Interestingly, when considered as a percentage of
the total myeloid cell-associated proteins, roughly 10% occur
FIG. 5. Antibody staining confirms novel NET identifications.
A, NET antibody validation by Western blotting. C17orf32 and
Tmem126A antibodies were tested on human PBMC lysates,
whereas C17orf62 antibodies were tested on a C2C12 lysate to check
background in the cell line used to test pre-extraction in D. MARCH5
antibodies were tested using the Jurkat human blood cell line. Aster-
isks indicate expected molecular weight. B, comparison of relative
NET amounts in ER (microsome) and NE fractions by quantitative
Western blotting. LAP2 and Tmem209 antibodies are NET controls,
whereas calreticulin antibodies are an ER control. Blots were quanti-
fied using a LI-COR Odyssey system (three repeats averaged).
C, cryosections of rat spleen stained with antibodies to new NETs and
a SUN2 control. Nuclear rim staining was clearly observed for all
NETs tested. Scale bars, 10 m. D, antibody staining on Triton-pre-
extracted C2C12 cells. A nuclear rim staining was observed for the
control NET SUN2 and all novel NETs tested.
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at the NE, indicating this organelle as a dynamic player in cell
type specification.
PHA-induced changes include physiologically relevant
functions such as re-entering the active cell cycle (43) and
altering peripheral chromatin organization (17). Individual
NETs could contribute to chromatin organization and tran-
scriptional regulation to facilitate one of the individual lineages
observed in Fig. 6C. To gauge the likelihood of NE contribu-
tions to genome functions, the known proteins in the NE data
sets (both NETs and soluble proteins) that had functional
annotations in the GO database were extracted. A separate
data set was extracted for all proteins in the GO database
associated with the nucleus. GO functional annotations were
then applied to these data sets, and the fraction of proteins
within each data set with a particular GO functional annotation
was calculated. These fractions were compared with one
another to give the -fold enrichment of a particular function at
the NE compared with that function as a fraction of activity
within the nucleus in general (Fig. 6, D–F). For example, tran-
scription takes place throughout the nucleus, and the nuclear
periphery is considered to be a generally transcriptionally
repressive environment (54): the fraction of proteins identified
at the NE involved in transcription, as thus expected, is much
lower than that for the nucleus, yielding a negative -fold value
of 3.5 (Fig. 6D). In contrast, proteins involved in nucleocy-
toplasmic transport would be expected to be enriched at the
NE compared with the nucleus as a whole, and the value
obtained for NPC proteins showed enrichment of 3.5-fold at
the NE (Fig. 6D).
The general functional categories varied little between un-
stimulated and PHA-activated PBMC NEs; however, analysis
of more specific subcategories revealed interesting differ-
ences. RNA functions, as might be expected, varied little upon
PHA activation except that a few more end-processing pro-
teins were found at the NE (Fig. 6E), consistent with an in-
creased burden of RNAs to be exported from the nucleus with
the significant gene activation resulting from PHA treatment.
Functions in epigenetic regulation yielded more dynamic
changes upon leukocyte activation (Fig. 6F). Chromatin si-
lencing functions were less enriched at the NE with PHA
activation, clearly indicating that changes at the NE play a role
in the major chromatin reorganization that takes place. NuRD
complex proteins in contrast were specifically enriched at the
NE upon PHA activation.
Novel NET Functions in Chromatin/Genome Organization—
The finding of so many known proteins with chromatin regu-
latory functions in these data sets that change between the
data sets in ways that match the physiological changes ob-
served in chromatin upon PHA activation argues that some
novel proteins identified might also have chromatin functions.
To screen for such NETs, we tested nine PBMC NETs in
assays for effects on genome organization.
The first assay utilized an HT1080-derived cell line carrying
a lacO repeat insertion in chromosome 5, the position of
FIG. 6. Differences in NE composition with PHA activation and
effects on genome organization. A, differences in abundance esti-
mated from dNSAF values for some NETs with or without PHA acti-
vation. dNSAF values were taken from the two most equivalent runs
based on total protein coverage and identifications. B, RT-PCR of the
NETs in A revealed reproducible differences in expression that are
consistent with their abundance estimates based on peptide recov-
eries. C, transcript levels for several of the NETs identified differ
among blood cell lineages. Data from the BioGPS transcriptome
study comparing 84 different tissues/cell types are plotted relative to
the median value over all 84 tissues sampled. Ticks along the bottom
are for increments of 5-fold above the median. Each NET had its own
unique expression pattern. Surface markers defining cell populations
were CD71 for early erythroid cells, CD14 for monocytes, CD33 for
myeloid cells, CD56 for natural killer (NK) cells, CD8 for T-cells,
BDCA4 for myeloid dendritic cells, CD19 for B-cells, 721 for B-
lymphoblasts, CD105 for endothelial cells, and CD34 for polyploidy
progenitor cells. Error bars in B and C indicate standard deviation.
D, within the subset of proteins in NE data sets with GO annotations, the
fraction with a particular functional annotation was calculated. Similar
fractions were calculated against all “nuclear”-annotated proteins in
the GO database. The ratio of NE/nuclear fractions was then calcu-
lated, setting a 1:1 ratio to 0 so that positive values are -fold enrich-
ment and negative values are -fold deficiency at the NE compared
with the whole nucleus. Resting and activated PBMC data sets are
represented by gray and black bars, respectively. E, the same analysis
applied to the specific subset associated with RNA functions. F, the
same analysis applied to the specific subset associated with func-
tions in epigenetic regulation. PcG, Polycomb group.
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which is visualized with a lac repressor-GFP fusion that binds
to the array. This lacO array tends to be in the nuclear interior.
These cells were transfected with expression constructs for
NET-mRFP fusions and assayed for a change in the distribu-
tion of the lacO array position with respect to the nuclear
periphery. If a NET altered the position of the lacO array by
pulling it to the nuclear periphery it could be considered to
function in genome organization (Fig. 7A, left). To determine
lacO positioning, a previously published algorithm was uti-
lized that erodes the nucleus based on DAPI staining for DNA
into five concentric rings of roughly equal area (55). The ring
containing the lacO array was marked in each cell and re-
corded (Fig. 7A, right). The NET C20orf3 had no effect on the
position of the lacO array; however, TAPBPL expression in-
creased the occurrence of the array at the periphery (Fig. 7B).
The ring containing the lacO array was marked in 100 cells,
and the distribution was plotted (Fig. 7C). The lacO array
tended to be in the nuclear interior, occurring in the peripheral
ring only 20% of the time. Most blood NETs tested yielded
no significant differences, but in cells expressing STT3A and
TAPBPL, the occurrence at the periphery roughly doubled in
multiple separate experiments with p values 
0.0015 and
0.0001, respectively (Fig. 7C).
For the second assay, the same set of blood NETs was
transfected into a HeLa cell line stably expressing H2B-GFP,
and cells were observed for general changes in overall chro-
matin distribution. The two NETs that had strong effects in the
lacO screen had no effect in this screen, further indicating that
the interactions pulling the locus to the periphery are specific.
A different NET, IAG2, had a strong effect on chromatin con-
densation (Fig. 8; compare with cells transfected with
C20orf3, C17orf32, and METTL7A in upper panels), and this
effect was repeated in all of three independent experiments. A
FIG. 7. Cell-based screen for PBMC NETs that promote recruit-
ment of chromosome loci to nuclear periphery. A, schematic rep-
resentation of a screen to determine whether overexpression of a
particular NET can recruit a specific chromatin locus to the NE. NETs
were transfected into cells containing a lacO repeat integration that is
typically in the interior. The lacO position was visualized with GFP-lacI
(green) and measured using an algorithm that partitions the nucleus
based on DAPI staining (blue) into five concentric circles of roughly
equal area. B, example of NET-transfected cells. The position of the
lacO locus is highlighted by the white arrows. The lacO locus position
is unaffected by C20orf3 expression but moves to the periphery with
TAPBPL expression. DAPI staining added to the merged image con-
firms that the movement of the locus is not an artifact of generalized
chromatin condensation at the periphery. Deconvolved images are
shown. C, the ring containing the locus was recorded in roughly 100
transfected cells. p values were calculated for NETs that increased
the locus at the periphery in comparison with untransfected (UT) or
mRFP-transfected control cells using a 2 test.
FIG. 8. Screen for PBMC NETs that promote chromatin com-
paction. HeLa cells stably expressing H2B-GFP were transfected
with the same set of nine NETs used in Fig. 7. Only IAG2 displayed
strong chromatin condensation, whereas all other NETs (METTL7A,
C17orf32, and C20orf3 are shown) exhibited no differences in chro-
matin compaction or distribution compared with adjacent untrans-
fected cells. It is noteworthy that IAG2 had no effect in the lacO
screen and that NETs STT3A and TAPBPL, which altered lacO posi-
tioning, had no effect on chromatin compaction.
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ring of condensed chromatin is noticeable at the periphery,
although the effect has clearly propagated throughout the
nucleus. Distribution of the NET alone in the left panels clearly
indicates that, whereas some of the overexpressed protein
has accumulated in the ER, none is in the nucleoplasm: thus,
the effect must be propagated from the NE.
DISCUSSION
This analysis of the leukocyte NE proteome identified many
more NE-associated proteins and NETs than an earlier study
of liver NEs (21). Moreover, some proteome differences were
observed between unstimulated and PHA-activated leuko-
cytes, many of which correspond to proteins that are ex-
pressed in only specific blood cell lineages. Many of these
new NETs appear to be tissue-specific, and our results further
show that NE protein composition changes in response to
chemical stimulation. These findings indicate the potential of
other organelle proteomes to vary with chemical treatments or
between tissues.
Large scale changes have been reported in the organization
of leukocyte peripheral chromatin upon PHA stimulation (17–
20). These data sets should contain both NETs and tightly
bound chromatin proteins involved in making these changes.
As several NETs have known associations with chromatin-
silencing proteins (12, 13), it is not surprising that several of
the proteins identified here in association with the NE had
functions in gene regulation and RNA processing. The PHA-
induced general decrease in epigenetic silencing factors is
consistent with the observed reduction in dense peripheral
chromatin. Contrasting with this, the specific relative increase
in NuRD complex proteins at the NE is interesting as this
chromatin remodeling complex plays roles in development
and was recently shown to function in progeria defects
caused by NE mutations (56).
NET developmental roles are consistent with the blood cell
type specificity of the two NETs that affected positioning
of the lacO array (25-fold higher in blood cells over other
tissues). Several tissue-specific genes move from the NE to
the nuclear interior during differentiation (e.g. IgH locus,
Mash1, and CFTR) (57–59); however, the NE proteins that
regulate NE tethering and release have yet to be identified.
Recent studies showed that tethering lac repressor to an NE
protein could recruit the lacO array to the periphery by an
affinity-based mechanism (14–16). As lac repressor was not
fused to the NETs used in our screen, the specific effects of
TAPBPL and STT3A likely operate through affinity for other
chromosome regions on the same chromosome as the lacO
array. This is consistent with the earlier studies showing that
the whole chromosome accompanied the array to the periph-
ery (14, 16). The interaction cannot be due to a more general
affinity for chromatin because if so it would increase chroma-
tin density at the periphery, and these two NETs had no effect
in the second screen for chromatin compaction. Thus, our
identification here of endogenous NETs that can alter the
positioning of genes/chromosomes in the nucleus appears to
reflect the unique chromatin characteristics of lymphocytes.
As several studies have implicated misregulation of chromatin
organization in NE diseases (7, 8), these new blood NETs may
contribute to the diverse pathologies associated with NE
diseases.
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